Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Current Leases (2019 - 2025)

Cumberland Pharmaceuticals (CPIX) has disclosed Current Leases for 7 consecutive years, with $467774.0 as the latest value for Q4 2025.

  • Quarterly Current Leases rose 31.21% to $467774.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $467774.0 through Dec 2025, up 31.21% year-over-year, with the annual reading at $467774.0 for FY2025, 31.21% up from the prior year.
  • Current Leases hit $467774.0 in Q4 2025 for Cumberland Pharmaceuticals, up from $401445.0 in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $1.1 million in Q3 2021 to a low of $158369.0 in Q1 2023.
  • Historically, Current Leases has averaged $506517.0 across 5 years, with a median of $381428.5 in 2024.
  • Biggest five-year swings in Current Leases: crashed 82.17% in 2022 and later skyrocketed 128.73% in 2024.
  • Year by year, Current Leases stood at $969677.0 in 2021, then plummeted by 82.17% to $172910.0 in 2022, then surged by 101.31% to $348092.0 in 2023, then grew by 2.42% to $356508.0 in 2024, then skyrocketed by 31.21% to $467774.0 in 2025.
  • Business Quant data shows Current Leases for CPIX at $467774.0 in Q4 2025, $401445.0 in Q3 2025, and $386077.0 in Q2 2025.